Publications by authors named "Thomas Stangler"

Claim this Profile
P
PDA Biosimilars Workshop Report (September 27-28, 2018)-Getting It Right the First Time for Biosimilar Marketing Applications.
Stephan Krause, Emanuela Lacana, Joel Welch, Marjorie Shapiro, Christopher Downey, Thomas Stangler

PDA J Pharm Sci Technol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining consistent quality and clinical performance of biopharmaceuticals.
William C Lamanna, Johann Holzmann, Hillel P Cohen, Xinghua Guo, Monika Schweigler, Thomas Stangler

Expert Opin Biol Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013.
Antonio da Silva, Ulrich Kronthaler, Vera Koppenburg, Martin Fink, Ines Meyer, Thomas Stangler

Leuk Lymphoma· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab.
Jan Visser, Isabel Feuerstein, Thomas Stangler, Timo Schmiederer, Cornelius Fritsch

BioDrugs· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptable changes in quality attributes of glycosylated biopharmaceuticals.
Martin Schiestl, Thomas Stangler, Claudia Torella, Tadej Cepeljnik, Hansjörg Toll

Nat Biotechnol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis.
Michael Melmer, Thomas Stangler, Andreas Premstaller, Wolfgang Lindner

J Chromatogr A· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals.
Michael Melmer, Thomas Stangler, Mark Schiefermeier, Werner Brunner, Hansjörg Toll

Anal Bioanal Chem· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the redox state of porous graphitic carbon on the retention of oligosaccharides.
Michael Melmer, Thomas Stangler, Andreas Premstaller, Wolfgang Lindner

J Chromatogr A· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solvent effects on the retention of oligosaccharides in porous graphitic carbon liquid chromatography.
Michael Melmer, Thomas Stangler, Andreas Premstaller, Wolfgang Lindner

J Chromatogr A· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nix directly binds to GABARAP: a possible crosstalk between apoptosis and autophagy.
Melanie Schwarten, Jeannine Mohrlüder, Peixiang Ma, Matthias Stoldt, Yvonne Thielmann, Thomas Stangler

Autophagy· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand binding mode of GABAA receptor-associated protein.
Oliver H Weiergräber, Thomas Stangler, Yvonne Thielmann, Jeannine Mohrlüder, Katja Wiesehan

J Mol Biol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An indole-binding site is a major determinant of the ligand specificity of the GABA type A receptor-associated protein GABARAP.
Yvonne Thielmann, Jeannine Mohrlüder, Bernd W Koenig, Thomas Stangler, Rudolf Hartmann

Chembiochem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of clathrin heavy chain as a direct interaction partner for the gamma-aminobutyric acid type A receptor associated protein.
Jeannine Mohrlüder, Yvonne Hoffmann, Thomas Stangler, Karen Hänel, Dieter Willbold

Biochemistry· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library.
Jeannine Mohrlüder, Thomas Stangler, Yvonne Hoffmann, Katja Wiesehan, Anja Mataruga

FEBS J· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide.
Thomas Stangler, Tuyen Tran, Silke Hoffmann, Holger Schmidt, Esther Jonas

Biol Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.
Holger Schmidt, Silke Hoffmann, Tuyen Tran, Matthias Stoldt, Thomas Stangler

J Mol Biol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains.
Karen Hänel, Thomas Stangler, Matthias Stoldt, Dieter Willbold

J Biomed Sci· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of human immunodeficiency virus type 1 Vpr(34-51) peptide in micelle containing aqueous solution.
Andrea Engler, Thomas Stangler, Dieter Willbold

Eur J Biochem· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solution structure of human GABA(A) receptor-associated protein GABARAP: implications for biolgoical funcrion and its regulation.
Thomas Stangler, Lorenz M Mayr, Dieter Willbold

J Biol Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis